The Claim
Conventional clinical markers including BMI, fasting glucose, and androgen levels fail to fully capture the metabolic heterogeneity of polycystic ovary syndrome, particularly in lean or centrally adipose South Asian women, resulting in underdiagnosis of insulin resistance and elevated cardiometabolic risk.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Standard medical tests like BMI, blood sugar, and hormone levels do not detect all cases of insulin resistance and heart disease risk in women with polycystic ovary syndrome, especially those who are lean or have fat around the waist and are of South Asian descent.
See the scientific wording
Conventional clinical markers such as BMI, fasting glucose, and androgen levels inadequately capture the metabolic heterogeneity of polycystic ovary syndrome (PCOS), particularly in lean or centrally adipose South Asian women, leading to underdiagnosis of insulin resistance and elevated cardiometabolic risk.
Fat stored around the organs in lean South Asian women with PCOS releases substances that block insulin action and disrupt hormone balance, making standard tests like weight and blood sugar miss the real metabolic danger.
What the research says
1 studyEven if South Asian women with PCOS aren’t overweight, they can still have serious metabolic problems like insulin resistance — but regular tests like weight and blood sugar often miss it. A new method that analyzes body chemicals finds these hidden risks better.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.